Axinn Advises McKesson on $875M Acquisition of Rx Savings Solutions
September 19, 2022
Axinn is representing McKesson Corporation (NYSE: MCK), a diversified health care services leader, in its $875M acquisition of Rx Savings Solutions, a prescription price transparency and benefit insight company. Announced on September 19, 2022, the acquisition will strengthen McKesson’s ability to help solve the most common medication challenges related to access, affordability and adherence. The Axinn team is led by partners Daniel Bitton and Jeny Maier, and assisted by associate Neelesh Moorthy.
To subscribe to our publications, click here.
Featured Insights
Featured Insights
ACI 22nd Annual Paragraph IV Conference
Speaking Engagement
Intellectual Property
Informa 35th Annual Advanced EU London Conference
Speaking Engagement
Antitrust
AHLA Health Care Transactions Program 2026
Sponsorship
Antitrust
Kenina Lee Selected as a Member of Law360’s 2026 Competition Editorial Advisory Board
Awards & Recognitions
Antitrust
Axinn Associates at the Antitrust Spring Meeting: You Get a Deal, You Get a Deal—A Deal in Every Environment
Axinn Viewpoints
Antitrust
Axinn Associates at the Spring Meeting: Trends in Federal Antitrust Enforcement and Policy
Axinn Viewpoints
Antitrust
Axinn Associates at the Antitrust Spring Meeting: Cartel Enforcement Trends and Developments
Axinn Viewpoints
Antitrust
Axinn Associates at the Antitrust Spring Meeting: Tech-Related Enforcement
Axinn Viewpoints
Antitrust
Leadership Across the Generations: A Conversation Between Mentor and Mentee
Byline Articles
Antitrust
Ultramarathons Make Me A Better Lawyer
Byline Articles
Antitrust